Stress-related disorders among young individuals with surgical removal of tonsils or adenoids

JAMA Network Open

2024-12-09

(Press-News.org) About The Study: The findings of this cohort study suggest that early-life surgical removal of tonsils or adenoids is associated with a higher future risk of stress-related disorders and highlight a need to understand the role of adenotonsillar diseases or associated health conditions in the development of stress-related psychiatric disorders.

Corresponding Author: To contact the corresponding author, Zhe Zhang, MD, PhD, email zhangzhe@gxmu.edu.cn.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamanetworkopen.2024.49807)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

# # #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time http://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.49807?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=120924

About JAMA Network Open: JAMA Network Open is an online-only open access general medical journal from the JAMA Network. On weekdays, the journal publishes peer-reviewed clinical research and commentary in more than 40 medical and health subject areas. Every article is free online from the day of publication.

END

ELSE PRESS RELEASES FROM THIS DATE:

RSV disease burden and nirsevimab effectiveness in young children from 2023-2024

2024-12-09

About The Study: This analysis documented the continued high burden of medically attended respiratory syncytial virus (RSV)-associated acute respiratory illness among young children in the U.S. Nirsevimab and maternal RSV vaccine uptake was low, but nirsevimab was effective against RSV-associated hospitalization. There is a potential for substantial public health impact with increased and equitable prevention product coverage in future seasons. Corresponding Author: To contact the corresponding author, Heidi L. Moline, MD, MPH, email ick6@cdc.gov. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamapediatrics.2024.5572) Editor’s ...

Brain tumor organoids accurately model patient response to CAR T cell therapy

2024-12-09

PHILADELPHIA— For the first time, researchers used lab-grown organoids created from tumors of individuals with glioblastoma (GBM) to accurately model a patient’s response to CAR T cell therapy in real time. The organoid’s response to therapy mirrored the response of the actual tumor in the patient’s brain. That is, if the tumor-derived organoid shrunk after treatment, so did the patient’s actual tumor, according to new research from the Perelman School of Medicine at the University of Pennsylvania, published today in Cell Stem Cell. “It’s hard to measure how a patient with GBM responds to treatment because we can’t regularly ...

New method enables protein analysis accounting for population diversity

2024-12-09

Analyzing the sequence of proteins in cohort studies is done by comparing participant data against protein sequences predicted from the human genome. – Today, the same reference proteins are used for all participants, says associate professor Marc Vaudel at the department of Clinical Science of the University of Bergen – but we are all different! We found that the small genetic changes that make us who we are create a bias: for those who differ from the reference, current informatic methods are blind to parts of their proteins. To solve this problem, the researchers in Bergen developed new models to build sequences from large genetic ...

Breaking new ground in health care: Setting the standard for XR clinical research with the RATE-XR guideline

2024-12-09

(Toronto, December 9, 2024) In a pivotal step toward improving research standards in health care technologies, the Journal of Medical Internet Research has published the RATE-XR guideline. This new tool aims to standardize reporting for early-phase clinical studies involving extended reality (XR) technologies such as virtual reality and augmented reality. Developed through a robust, expert-driven process, RATE-XR addresses critical gaps in transparency, safety, and ethical reporting, ensuring XR applications meet the needs of patients and researchers alike. Led by a multidisciplinary team of international experts, RATE-XR offers a checklist comprising 17 XR-specific ...

Unlocking worm strategies: A path to innovative vaccines and therapies

2024-12-09

A research team led by Prof. Julia Esser-von Bieren from the Center of Allergy and Environment (ZAUM) at Helmholtz Munich and the Technical University of Munich, as well as the University of Lausanne (UNIL) has uncovered a molecular strategy employed by worm parasites (helminths) to evade host immune defenses. This discovery opens new avenues for the development of innovative vaccines and therapies. Published in Science Immunology, the study offers promising solutions for addressing major infectious diseases, allergies, and asthma by leveraging ...

Students are less likely to feel safe at their schools, compared to staff and parents

2024-12-09

AUSTIN, TX, Dec 9, 2024 – School shooting incidents have doubled in the last three years, according to the K-12 School Shooting Database, which tracks each time a firearm is discharged on school property. Many schools have taken measures to improve safety, including metal detectors, interior door locks, emergency drills, and undercover security. But do students and staff feel any safer? Researchers at the University of Southern California (USC) conducted a nationwide study of K-12 parents, K-12 teachers, and recently graduated high school students to test their responses ...

SwRI announces joint industry program aimed at advancing heavy-duty hydrogen refueling infrastructure

2024-12-09

SAN ANTONIO — December 9, 2024 —Southwest Research Institute has announced a groundbreaking joint industry project (JIP) to help spur the growth and innovation of fueling technologies and infrastructure for hydrogen-powered heavy-duty vehicles. SwRI’s H2HD REFUEL (Hydrogen Heavy Duty Refueling Equipment and Facilities Utilization Evaluation Laboratory) JIP aims to strengthen the acceptance of hydrogen fuel use by heavy-duty vehicles to help the mobility industry meet its decarbonization and zero-emissions goals by advancing hydrogen refueling station (HRS) technologies. Over the next four years, SwRI researchers will use hands-on ...

Webb telescope’s largest study of universe expansion confirms challenge to cosmic theory

2024-12-09

New observations from the James Webb Space Telescope suggest that a new feature in the universe—not a flaw in telescope measurements—may be behind the decadelong mystery of why the universe is expanding faster today than it did in its infancy billions of years ago. The new data confirms Hubble Space Telescope measurements of distances between nearby stars and galaxies, offering a crucial cross-check to address the mismatch in measurements of the universe’s mysterious expansion. Known as the Hubble tension, the discrepancy remains unexplained even by the best cosmology models. “The ...

By age six, children think boys are better than girls at computing and engineering, new American Institutes for Research study shows

2024-12-09

Arlington, Va. – Children as young as age 6 develop gender stereotypes about computer science and engineering, viewing boys as more capable than girls, according to new results from an American Institutes for Research (AIR) study. However, math stereotypes are far less gendered, showing that young children do not view all science, technology, engineering, and math (STEM) fields as the same. These new findings come from the largest-ever study on children’s gender stereotypes about STEM and verbal abilities, based on data from 145,000 children across 33 nations, synthesizing more than 40 years of ...

Hair growth drug safe at low doses for breast cancer patients

2024-12-09

Hair loss during chemotherapy can cause enough distress for some women to lose self-confidence, which experts say may discourage them from seeking chemotherapy in the first place. Oral minoxidil is a commonly prescribed treatment for hair loss. The drug is also the active ingredient in over-the-counter Rogaine. The prescription treatment is known, however, to dilate blood vessels, and experts worry that this could increase the heart-related side effects of chemotherapy and lead to chest pain, shortness of breath, or fluid buildup. Now, a study in women with breast cancer suggests that low oral doses of minoxidil, taken during ...

Stress-related disorders among young individuals with surgical removal of tonsils or adenoids

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: